Latest / Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals
RHAPSODY Trial Results: Recurrent Pericarditis with Rilonacept
Dr. Allan Klein, Director of Cleveland Clinic’s Pericardial Disease Center, provides the results of the RHAPSODY trial, a pivotal Phase 3 trial that evaluated rilonacept, an interleukin 1-α and 1-β inhibitor, compared with placebo among patients with recurrent pericarditis. Study design and findings are provided, as well as implications for future care for patients with pericarditis.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.